Oral Cancer Research

More than a quarter of a million individuals are diagnosed with oral cancer annually and two thirds of these are diagnosed in developing countries, with the highest incidence in South East Asia. Unfortunately, 50% of oral cancer patients die within 5 years of their diagnosis and those who have been successfully treated need to cope with the devastating consequences of their treatment involving their appearance and function. While the poor survival rate of oral cancer reflect late diagnosis, this is also attributed to our poor understanding of how this cancer is initiated or developed. The aim of the Oral Cancer Research Team program is to obtain a comprehensive understanding of the genes that cause oral cancer development, and to use this as a basis to develop molecular tools for early detection and treatment. We are working towards targeted therapy to effective treat the tumour and avoid harming normal cells.  Find out more below: